Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Classement en actions #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Prix de l'action
$0.12164306
Dernière synchronisation: 2024-11-11
Capitalisation boursière
$38.53M
Changement (1 jour)
-4.14%
Changement (1 an)
0.00%
Pays
AU
Échange PharmAust Limited (PAA)

Catégorie

Historique des divisions d’actions pour PharmAust Limited (PAA)
L’action PharmAust Limited (symbole : PAA) a subi un total de 4 divisions.
La division la plus récente a eu lieu le Feb 20, 2019.
Une action PAA achetée avant le Nov 15, 2004 équivaudrait aujourd’hui à 0.011443846153846 actions PAA.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
2019-02-20 551:500 x1.102 x0.011443846153846
2016-11-10 27:26 x1.0384615384615 x0.010384615384615
2015-10-30 1:20 x0.05 x0.01
2004-11-15 1:5 x0.2 x0.2
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH